Loading clinical trials...
Loading clinical trials...
Clinical Feasibility Study of the Magenta Elevate™ Percutaneous Left Ventricular Assist Device (pLVAD) System in Patients With Cardiogenic Shock
Conditions
Interventions
Elevate™ System
Locations
5
Georgia
Israeli-Georgian Medical Research Clinic Helsicore
Tbilisi, Georgia
Tbilisi Heart Center
Tbilisi, Georgia
Shamir Medical Center
Be’er Ya‘aqov, Israel
Rambam Medical Center
Haifa, Israel
Tel-Aviv Sourasky Medical Center
Tel Aviv, Israel
Start Date
November 5, 2025
Primary Completion Date
May 30, 2026
Completion Date
October 30, 2026
Last Updated
February 27, 2026
NCT07083011
NCT07550790
NCT07037459
NCT06638268
NCT06874556
NCT04295252
Lead Sponsor
Magenta Medical Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions